Market Overview

UPDATE: Susquehanna Downgrades Lennar

Share:
Related LEN
Wednesday's Mid-Day Movers: Fitbit, Transition Therapeutics Losing Big; Celator Pharma, MeetMe Up
Benzinga's Volume Movers
Lennar Corp. (LEN) Up to Strong Buy on Solid Q2 Results - Analyst Blog (Zacks)

On Friday, Susquehanna downgraded shares of Lennar (NYSE: LEN) from Positive to Neutral and lowered the price target from $46 to $43.

The downgrade was valuation-based to better reflect seasonal shifts compared to Susquehanna's October upgrade, said analyst Jack Micenko.

First quarter results were “solid, said Micenko. The analyst is encouraged by “clear signs” of improving volume voiced by Lennar management.

Shares of Lennar are down 1.9 percent to $39.55. The stock is flat year-to-date.

Latest Ratings for LEN

DateFirmActionFromTo
Jun 2015Credit SuisseMaintainsNeutral
May 2015Raymond JamesDowngradesOutperformMarket Perform
May 2015BarclaysUpgradesEqual-weightOverweight

View More Analyst Ratings for LEN
View the Latest Analyst Ratings

Posted-In: Jack Micenko SusquehannaAnalyst Color Analyst Ratings

 

Related Articles (LEN)

Around the Web, We're Loving...

Get Benzinga's Newsletters